Lunaphore and Propath share perspectives on the rapidly evolving spatial biology landscape, through an interview with Kelly Hunter, Chief Scientific Officer at Propath.
In the interview, Kelly discusses the growing importance of spatially resolved technologies in understanding disease biology, as well as the challenges associated with generating and interpreting complex datasets. The conversation also explores how integrated workflows, combining wet-lab capabilities with advanced bioinformatics, are enabling more meaningful insights from tissue samples.
The feature reflects Propath’s position at the forefront of spatial biology and multiomics, and its commitment to supporting biopharma clients with innovative, high-quality solutions across the drug development pipeline.
Click here to see a video of the conversation with Kelly Hunter, CSO, Propath.
